| Pharmaceutical active ingredients: |
| Hydrocortisone AcetateNeomycin Sulfate |
| Available forms, composition and doses of Neo Hubber: |
| N / A |
| Neo Hubber medical category: |
| Human:Topical anti-infectives with corticosteroidsTopical corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Teofarma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Hycocin | Hydrocortisone Acetate; Neomycin Sulfate | Rekah |
| Hycomycin | Hydrocortisone Acetate; Neomycin Sulfate | Teva |
| Hydrocortimycin | Hydrocortisone Acetate; Neomycin Sulfate | Dr. Kolassa & Merz |
| Idrocet | Hydrocortisone Acetate; Neomycin Sulfate | Istituto Luso Farmaco d'Italia |
| Leuco Hubber | Hydrocortisone Acetate; Neomycin Sulfate | Sanofi-Aventis; Teofarma |
| Neo-Cortef | Hydrocortisone Acetate; Neomycin Sulfate | Pfizer; Pliva |
| Neoderm | Hydrocortisone Acetate; Neomycin Sulfate | Adcock Ingram |
| Neo-Hydro | Hydrocortisone Acetate; Neomycin Sulfate | Upha Corporation; Beacons Pharmaceuticals; G. Streuli |
| Neo-Hytisone | Hydrocortisone Acetate; Neomycin Sulfate | Atlantic Pharmaceutical |
| Nufacort | Hydrocortisone Acetate; Neomycin Sulfate | Nufarindo Pharmaceutical Laboratories |